Feb 15, 2024 / 01:00PM GMT
Operator
Good morning and welcome to Agios' Fourth Quarter 2023 conference call. At this time, all participants are in a listen only mode. There'll be a question and answer session at the end. Please be advised that this call is being recorded our deals request.
I would now like to turn the call over to Chris Taylor, Vice President, Investor Relations and Corporate Communications for Agios. Please go ahead.
Christopher Taylor - Agios Pharmaceuticals Inc - Vice President, Investor Relations and Corporate Communications
Thank you, operator. Good morning, everyone, and welcome to Agios' conference call and webcast to discuss fourth quarter and full year 2023 financial results. And recent business highlights. You can access slides for today's call by going to the Investors section of our website at Agios.com. On today's call, I'm joined by our Chief Executive Officer, Brian Goff, Dr. Sarah Hewitt's, Chief Medical Officer and Head of Research and Development Center melanoma, our Chief Commercial Officer, and Cecilia Jones, Chief Financial Officer.
Before we
Q4 2023 Agios Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot